FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 2780419 · Received October 10, 2012

Report

Report Number
2124215-2012-12273
Event Type
Injury
Date Received
October 10, 2012
Date of Event
September 11, 2012
Report Date
September 11, 2012
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED A GRADUAL INCREASE IN IMPEDANCE MEASUREMENTS TO 1900 OHMS. IT WAS INDICATED THAT THERE WAS AN INCREASE OF MORE THAN 500 OHMS BETWEEN MEASUREMENTS. ADDITIONALLY, THE THRESHOLD MEASUREMENTS INCREASED. AS A RESULT, THIS LEAD WAS SURGICALLY ABANDONED AND A NEW LEAD WAS SUCCESSFULLY IMPLANTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0175

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R 0175